Additionally, ageing might also impact BC biology: compared to younger patients, older women often develop less aggressive tumors that are mostly oestrogen receptor (ER)‐positive, lack over‐expression of human epidermal growth factor receptor‐2 (HER2) and have lower proliferation rates (luminal A‐like tumors). Here, ERBB2 is linked to breast cancer.